-+ 0.00%
-+ 0.00%
-+ 0.00%

Astria Therapeutics Q1 EPS $(0.58) Misses $(0.48) Estimate

Benzinga·05/13/2025 21:55:37
Listen to the news
Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.48) by 20.83 percent. This is a 52.63 percent decrease over losses of $(0.38) per share from the same period last year.